Global Botulism Treatment Market Size, Status and Forecast 2018-2025

Date: Oct 15 2018
|
QYRESEARCH
|
Number of Pages: 92
|
Alternate Text Alternate Text Alternate Text Alternate Text

Botulism is a type of poisoning or infection caused by certain bacteria on the preserved food material.
The overall botulism market also provides a detailed analysis of the type and treatment in various regions which includes Americas, Europe, Asia Pacific and Rest of the World. Americas lead the botulism market owing to the largest number of botulism cases every year.
In 2017, the global Botulism Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Botulism Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Botulism Treatment development in United States, Europe and China.

The key players covered in this study
XOMA (U.S.)
Microbiotix (U.S.)
Valeant Pharmaceuticals (Canada)
Morphotek (U.S.)
Medytox Solutions (U.S.)
Lanzhou Institute of Biological Products (China)
Mentor Corporation and Metabiologics (U.S.)
Merz Pharma (Germany)
Allergan (Irish)
Galderma (Switzerland)

Market segment by Type, the product can be split into
Antitoxin
Antibiotics
Others

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Botulism Treatment status, future forecast, growth opportunity, key market and key players.
To present the Botulism Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Botulism Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global Botulism Treatment Market Size Growth Rate by Type (2013-2025)
           1.4.2 Antitoxin
           1.4.3 Antibiotics
           1.4.4 Others
    1.5 Market by Application
           1.5.1 Global Botulism Treatment Market Share by Application (2013-2025)
           1.5.2 Hospitals and Clinics
           1.5.3 Others
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Botulism Treatment Market Size
    2.2 Botulism Treatment Growth Trends by Regions
           2.2.1 Botulism Treatment Market Size by Regions (2013-2025)
           2.2.2 Botulism Treatment Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Botulism Treatment Market Size by Manufacturers
           3.1.1 Global Botulism Treatment Revenue by Manufacturers (2013-2018)
           3.1.2 Global Botulism Treatment Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global Botulism Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Botulism Treatment Key Players Head office and Area Served
    3.3 Key Players Botulism Treatment Product/Solution/Service
    3.4 Date of Enter into Botulism Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Botulism Treatment Market Size by Type (2013-2018)
    4.2 Global Botulism Treatment Market Size by Application (2013-2018)
5 United States
    5.1 United States Botulism Treatment Market Size (2013-2018)
    5.2 Botulism Treatment Key Players in United States
    5.3 United States Botulism Treatment Market Size by Type
    5.4 United States Botulism Treatment Market Size by Application
6 Europe
    6.1 Europe Botulism Treatment Market Size (2013-2018)
    6.2 Botulism Treatment Key Players in Europe
    6.3 Europe Botulism Treatment Market Size by Type
    6.4 Europe Botulism Treatment Market Size by Application
7 China
    7.1 China Botulism Treatment Market Size (2013-2018)
    7.2 Botulism Treatment Key Players in China
    7.3 China Botulism Treatment Market Size by Type
    7.4 China Botulism Treatment Market Size by Application
8 Japan
    8.1 Japan Botulism Treatment Market Size (2013-2018)
    8.2 Botulism Treatment Key Players in Japan
    8.3 Japan Botulism Treatment Market Size by Type
    8.4 Japan Botulism Treatment Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Botulism Treatment Market Size (2013-2018)
    9.2 Botulism Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Botulism Treatment Market Size by Type
    9.4 Southeast Asia Botulism Treatment Market Size by Application
10 India
    10.1 India Botulism Treatment Market Size (2013-2018)
    10.2 Botulism Treatment Key Players in India
    10.3 India Botulism Treatment Market Size by Type
    10.4 India Botulism Treatment Market Size by Application
11 Central & South America
    11.1 Central & South America Botulism Treatment Market Size (2013-2018)
    11.2 Botulism Treatment Key Players in Central & South America
    11.3 Central & South America Botulism Treatment Market Size by Type
    11.4 Central & South America Botulism Treatment Market Size by Application
12 International Players Profiles
    12.1 XOMA (U.S.)
           12.1.1 XOMA (U.S.) Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 Botulism Treatment Introduction
           12.1.4 XOMA (U.S.) Revenue in Botulism Treatment Business (2013-2018)
           12.1.5 XOMA (U.S.) Recent Development
    12.2 Microbiotix (U.S.)
           12.2.1 Microbiotix (U.S.) Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 Botulism Treatment Introduction
           12.2.4 Microbiotix (U.S.) Revenue in Botulism Treatment Business (2013-2018)
           12.2.5 Microbiotix (U.S.) Recent Development
    12.3 Valeant Pharmaceuticals (Canada)
           12.3.1 Valeant Pharmaceuticals (Canada) Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 Botulism Treatment Introduction
           12.3.4 Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2013-2018)
           12.3.5 Valeant Pharmaceuticals (Canada) Recent Development
    12.4 Morphotek (U.S.)
           12.4.1 Morphotek (U.S.) Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 Botulism Treatment Introduction
           12.4.4 Morphotek (U.S.) Revenue in Botulism Treatment Business (2013-2018)
           12.4.5 Morphotek (U.S.) Recent Development
    12.5 Medytox Solutions (U.S.)
           12.5.1 Medytox Solutions (U.S.) Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 Botulism Treatment Introduction
           12.5.4 Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2013-2018)
           12.5.5 Medytox Solutions (U.S.) Recent Development
    12.6 Lanzhou Institute of Biological Products (China)
           12.6.1 Lanzhou Institute of Biological Products (China) Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 Botulism Treatment Introduction
           12.6.4 Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2013-2018)
           12.6.5 Lanzhou Institute of Biological Products (China) Recent Development
    12.7 Mentor Corporation and Metabiologics (U.S.)
           12.7.1 Mentor Corporation and Metabiologics (U.S.) Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 Botulism Treatment Introduction
           12.7.4 Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2013-2018)
           12.7.5 Mentor Corporation and Metabiologics (U.S.) Recent Development
    12.8 Merz Pharma (Germany)
           12.8.1 Merz Pharma (Germany) Company Details
           12.8.2 Company Description and Business Overview
           12.8.3 Botulism Treatment Introduction
           12.8.4 Merz Pharma (Germany) Revenue in Botulism Treatment Business (2013-2018)
           12.8.5 Merz Pharma (Germany) Recent Development
    12.9 Allergan (Irish)
           12.9.1 Allergan (Irish) Company Details
           12.9.2 Company Description and Business Overview
           12.9.3 Botulism Treatment Introduction
           12.9.4 Allergan (Irish) Revenue in Botulism Treatment Business (2013-2018)
           12.9.5 Allergan (Irish) Recent Development
    12.10 Galderma (Switzerland)
           12.10.1 Galderma (Switzerland) Company Details
           12.10.2 Company Description and Business Overview
           12.10.3 Botulism Treatment Introduction
           12.10.4 Galderma (Switzerland) Revenue in Botulism Treatment Business (2013-2018)
           12.10.5 Galderma (Switzerland) Recent Development
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table Botulism Treatment Key Market Segments
Table Key Players Botulism Treatment Covered
Table Global Botulism Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Botulism Treatment Market Size Market Share by Type 2013-2025
Figure Antitoxin Figures
Table Key Players of Antitoxin
Figure Antibiotics Figures
Table Key Players of Antibiotics
Figure Others Figures
Table Key Players of Others
Table Global Botulism Treatment Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Others Case Studies
Figure Botulism Treatment Report Years Considered
Table Global Botulism Treatment Market Size 2013-2025 (Million US$)
Figure Global Botulism Treatment Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Botulism Treatment Market Size by Regions 2013-2025 (Million US$)
Table Global Botulism Treatment Market Size by Regions 2013-2018 (Million US$)
Table Global Botulism Treatment Market Share by Regions 2013-2018
Figure Global Botulism Treatment Market Share by Regions 2013-2018
Figure Global Botulism Treatment Market Share by Regions 2018
Table Market Top Trends
Table Global Botulism Treatment Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Botulism Treatment Market Share by Manufacturers (2013-2018)
Figure Global Botulism Treatment Market Share by Manufacturers in 2018
Table Global Botulism Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Botulism Treatment Product/Solution/Service
Table Date of Enter into Botulism Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table Global Botulism Treatment Market Size Share by Type (2013-2018)
Figure Global Botulism Treatment Market Size Market Share by Type (2013-2018)
Table Global Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table Global Botulism Treatment Market Size Share by Application (2013-2018)
Figure Global Botulism Treatment Market Size Market Share by Application (2013-2018)
Figure Global Botulism Treatment Revenue Market Share by Application in 2017
Figure United States Botulism Treatment Market Size 2013-2018 (Million US$)
Table United States Key Players Botulism Treatment Revenue (2017-2018) (Million US$)
Table United States Key Players Botulism Treatment Market Share (2017-2018)
Table United States Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table United States Botulism Treatment Market Share by Type (2013-2018)
Table United States Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table United States Botulism Treatment Market Share by Application (2013-2018)
Figure Europe Botulism Treatment Market Size 2013-2018 (Million US$)
Table Europe Key Players Botulism Treatment Revenue (2017-2018) (Million US$)
Table Europe Key Players Botulism Treatment Market Share (2017-2018)
Table Europe Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table Europe Botulism Treatment Market Share by Type (2013-2018)
Table Europe Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table Europe Botulism Treatment Market Share by Application (2013-2018)
Figure China Botulism Treatment Market Size 2013-2018 (Million US$)
Table China Key Players Botulism Treatment Revenue (2017-2018) (Million US$)
Table China Key Players Botulism Treatment Market Share (2017-2018)
Table China Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table China Botulism Treatment Market Share by Type (2013-2018)
Table China Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table China Botulism Treatment Market Share by Application (2013-2018)
Figure Japan Botulism Treatment Market Size 2013-2018 (Million US$)
Table Japan Key Players Botulism Treatment Revenue (2017-2018) (Million US$)
Table Japan Key Players Botulism Treatment Market Share (2017-2018)
Table Japan Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table Japan Botulism Treatment Market Share by Type (2013-2018)
Table Japan Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table Japan Botulism Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Botulism Treatment Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Botulism Treatment Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Botulism Treatment Market Share (2017-2018)
Table Southeast Asia Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Botulism Treatment Market Share by Type (2013-2018)
Table Southeast Asia Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Botulism Treatment Market Share by Application (2013-2018)
Figure India Botulism Treatment Market Size 2013-2018 (Million US$)
Table India Key Players Botulism Treatment Revenue (2017-2018) (Million US$)
Table India Key Players Botulism Treatment Market Share (2017-2018)
Table India Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table India Botulism Treatment Market Share by Type (2013-2018)
Table India Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table India Botulism Treatment Market Share by Application (2013-2018)
Figure Central & South America Botulism Treatment Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Botulism Treatment Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Botulism Treatment Market Share (2017-2018)
Table Central & South America Botulism Treatment Market Size by Type (2013-2018) (Million US$)
Table Central & South America Botulism Treatment Market Share by Type (2013-2018)
Table Central & South America Botulism Treatment Market Size by Application (2013-2018) (Million US$)
Table Central & South America Botulism Treatment Market Share by Application (2013-2018)
Table XOMA (U.S.) Company Details
Table XOMA (U.S.) Revenue in Botulism Treatment Business (2013-2018) (Million US$)
Figure XOMA (U.S.) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table XOMA (U.S.) Recent Development
Table Microbiotix (U.S.) Company Details
Table Microbiotix (U.S.) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Microbiotix (U.S.) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Microbiotix (U.S.) Recent Development
Table Valeant Pharmaceuticals (Canada) Company Details
Table Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Valeant Pharmaceuticals (Canada) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Valeant Pharmaceuticals (Canada) Recent Development
Table Morphotek (U.S.) Company Details
Table Morphotek (U.S.) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Morphotek (U.S.) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Morphotek (U.S.) Recent Development
Table Medytox Solutions (U.S.) Company Details
Table Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Medytox Solutions (U.S.) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Medytox Solutions (U.S.) Recent Development
Table Lanzhou Institute of Biological Products (China) Company Details
Table Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Lanzhou Institute of Biological Products (China) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Lanzhou Institute of Biological Products (China) Recent Development
Table Mentor Corporation and Metabiologics (U.S.) Company Details
Table Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Mentor Corporation and Metabiologics (U.S.) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Mentor Corporation and Metabiologics (U.S.) Recent Development
Table Merz Pharma (Germany) Company Details
Table Merz Pharma (Germany) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Merz Pharma (Germany) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Merz Pharma (Germany) Recent Development
Table Allergan (Irish) Company Details
Table Allergan (Irish) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Allergan (Irish) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Allergan (Irish) Recent Development
Table Galderma (Switzerland) Company Details
Table Galderma (Switzerland) Revenue in Botulism Treatment Business (2013-2018)(Million US$)
Figure Galderma (Switzerland) Revenue Growth Rate in Botulism Treatment Business (2013-2018)
Table Galderma (Switzerland) Recent Development
Table Global Botulism Treatment Market Size by Regions (Million US$) 2018-2025
Figure Global Botulism Treatment Market Size Share by Regions (2018-2025)
Figure Global Botulism Treatment Market Size Share by Regions in 2025
Figure United States Botulism Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Europe Botulism Treatment Market Size Forecast (2018-2025)(Million USD)
Figure China Botulism Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Japan Botulism Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Botulism Treatment Market Size Forecast (2018-2025)(Million USD)
Figure India Botulism Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Botulism Treatment Market Size Forecast (2018-2025)(Million USD)
Table Global Botulism Treatment Market Size by Product (2018-2025) (Million US$)
Figure Global Botulism Treatment Market Size by Product (2018-2025)
Figure Global Botulism Treatment Market Size by Product in 2025
Table Global Botulism Treatment Market Size by Application (2018-2025) (Million US$)
Figure Global Botulism Treatment Market Size by Application (2018-2025)
Figure Global Botulism Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.